Inhibition of the mevalonate pathway enhances cancer cell oncolysis mediated by M1 virus
Oncolytic viruses selectively kill tumour cells and induce anti-tumour immunity. Here, the AUs demonstrate the anti-viral effect of the mevalonate pathway on oncolytic virus M1 in refractory cancer cells and provide evidence for a combination strategy of targeting the mevalonate pathway for potentia...
Guardado en:
Autores principales: | Jiankai Liang, Li Guo, Kai Li, Xiao Xiao, Wenbo Zhu, Xiaoke Zheng, Jun Hu, Haipeng Zhang, Jing Cai, Yaya Yu, Yaqian Tan, Chuntao Li, Xincheng Liu, Cheng Hu, Ying Liu, Pengxin Qiu, Xingwen Su, Songmin He, Yuan Lin, Guangmei Yan |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2018
|
Materias: | |
Acceso en línea: | https://doaj.org/article/eedd8026eda94f72a09d4f75de768ad5 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
DNA-PK inhibition synergizes with oncolytic virus M1 by inhibiting antiviral response and potentiating DNA damage
por: Xiao Xiao, et al.
Publicado: (2018) -
Visualizing the enzyme mechanism of mevalonate diphosphate decarboxylase
por: Chun-Liang Chen, et al.
Publicado: (2020) -
Effect of levels of acetate on the mevalonate pathway of Borrelia burgdorferi.
por: Tricia A Van Laar, et al.
Publicado: (2012) -
Mechanisms that allow vaccination against an oncolytic vesicular stomatitis virus-encoded transgene to enhance safety without abrogating oncolysis
por: Amanda W. K. AuYeung, et al.
Publicado: (2021) -
In silico/computational analysis of mevalonate pyrophosphate decarboxylase gene families in Campanulids
por: Cui Minghui, et al.
Publicado: (2021)